title: Does pre-existing cognitive impairment no-dementia influence the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia?
authors.affiliation: Department of Neurology, University Lille North of France, UDSL, , Lille, France.
authors.forename: Kei
authors.initials: K
authors.lastname: Murao
authors.forename: Marie
authors.initials: M
authors.lastname: Bodenant
authors.forename: Charlotte
authors.initials: C
authors.lastname: Cordonnier
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Bombois
authors.forename: Hilde
authors.initials: H
authors.lastname: Hénon
authors.forename: Florence
authors.initials: F
authors.lastname: Pasquier
authors.forename: Régis
authors.initials: R
authors.lastname: Bordet
authors.forename: Didier
authors.initials: D
authors.lastname: Leys
mesh_terms: D061605:Administration, Intravenous; D000368:Aged; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy*; D016022:Case-Control Studies; D003072:Cognition Disorders / Q000150:complications / Q000188:drug therapy*; D003704:Dementia / Q000175:diagnosis; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
keywords: CEREBROVASCULAR DISEASE; COGNITION; DEMENTIA; STROKE